Literature DB >> 2158132

Immune effector mechanisms in inflammatory myopathies.

A G Engel1, K Arahata, A Emslie-Smith.   

Abstract

PM, IBM, and DM represent the commonly occurring inflammatory myopathies. In DM, the effector response appears to be predominantly humoral and directed against intramuscular blood vessels; a local humoral response may occur in muscle itself. Capillary lysis precedes other pathologic changes, suggesting that the capillary endothelium is an early and possibly primary target of the immune response. Questions remain about the role of immune complexes versus circulating antibodies, whether the muscle fiber injury can be explained by ischemia alone, and the possible role of endomysial CD8+ T cells. In PM and IBM, there is evidence for T-cell mediated cytotoxicity against the muscle fibers; however, muscle fiber destruction also could result from antibody-dependent complement-mediated lysis of the sarcolemma. Questions remain about the identity of the muscle fiber surface antigen(s) recognized by T cells and the molecular mechanisms of T-cell-mediated muscle fiber destruction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158132

Source DB:  PubMed          Journal:  Res Publ Assoc Res Nerv Ment Dis        ISSN: 0091-7443


  13 in total

1.  Increased levels of HSPA5 in the serum of patients with inflammatory myopathies--preliminary findings.

Authors:  Fei Xiao; Jia-Ze Tan; Xiao-Yan Xu; Xue-Feng Wang
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

2.  Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.

Authors:  T Mozaffar; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 3.  Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.

Authors:  Conrad C Weihl; Alan Pestronk
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

4.  Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes.

Authors:  D Michaelis; N Goebels; R Hohlfeld
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 5.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 6.  Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature.

Authors:  Hui-Jung Kim; Yun-Kyung Hong; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

7.  Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han.

Authors:  Qian Wang; Si Chen; Yuan Li; Ping Li; Chanyuan Wu; Ziyan Wu; Qingjun Wu; Fei Sun; Jing Li; Wenjie Zheng; Chuiwen Deng; Fengchun Zhang; Yongzhe Li
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.

Authors:  T P O'Hanlon; W A Messersmith; M C Dalakas; P H Plotz; F W Miller
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

9.  A crucial role of L-selectin in C protein-induced experimental polymyositis in mice.

Authors:  Kyosuke Oishi; Yasuhito Hamaguchi; Takashi Matsushita; Minoru Hasegawa; Naoko Okiyama; Jens Dernedde; Marie Weinhart; Rainer Haag; Thomas F Tedder; Kazuhiko Takehara; Hitoshi Kohsaka; Manabu Fujimoto
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

Review 10.  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Vivianne Malmström; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.